Home › Uterine Cancer › California
Uterine Cancer clinical trials in California
9 studies for Uterine Cancer are looking for participants at sites in California.
Cities in California
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- City of Hope Medical Center, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494Investigations of Reproductive Cancers in Women
- Sutter Health, San Carlos
RecruitingObservational study
Ages 45 to 100 · Women · Updated Aug 17, 2026 · NCT06527157Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of California Los Angeles Medical Center, Los Angeles
- University of California, San Diego; Moores Cancer Center, San Diego
- USOR Sansum Clinic, Santa Barbara
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, La Jolla
- Research Site, Orange
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · Women · Updated Dec 11, 2025 · NCT06795009Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
- Stanford University, Palo Alto
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2025 · NCT07044505From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.